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Summary
Background Different populations of unipotent or multipotent stem cells have been
identified in human epidermis and its appendages. It is well documented that
these cells maintain tissue homeostasis and actively participate in epidermal
regeneration after injury. However, there is no evidence of the presence of
pluripotent stem cells in human epidermis.
Objectives In this study we investigated whether cells positive for embryonic stem
cell marker stage-specific embryonic antigen-4 (SSEA-4) are present in adult
human epidermis and, if so, whether they are pluripotent and correspond to the
population of primitive stem cells.
Methods The expressions of SSEA-4 and pluripotency transcription factors were
analysed using flow cytometry. By means of immunohistochemical staining, we
studied the exact localization of these cells in sections of human skin.
Results We show that a population of SSEA-4+ cells is present in human
epidermis. In contrast to the commonly accepted belief, the expression of SSEA-4
is not connected with the pluripotent character of isolated cells. We found that
these SSEA-4+ cells are localized in the ducts of eccrine sweat glands.
Conclusions Our results indicate that SSEA-4 is a novel marker identifying the duc-
tal cells of human sweat glands. The surface character of the antigen provides for
a simple method of isolating this cell population and suggests applications of
SSEA-4 for future cell therapy research.
What’s already known about this topic?
• Different populations of unipotent and multipotent but not pluripotent stem cells
have been identified in human epidermis and its appendages.
• Stage-specific embryonic antigen-4 (SSEA-4) is a surface antigen commonly used to
identify pluripotent embryonic stem cells.
• Sweat gland cells not only regenerate the gland but may also contribute to epider-
mal cells after skin injury.
• There are no data identifying cell surface markers specific only for the ductal cells
of sweat glands.
What does this study add?
• SSEA-4-positive cells are present in human epidermis but lack pluripotency.
• SSEA-4 is the first marker characteristic of ductal but not secretory cells of sweat
glands to be described.
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What is the translational message?
• Currently, no effective treatment exists for patients after deep and extensive burns
or for those who were born with dysfunctional sweat glands and suffer from
hyperthermia. Cell therapy may be the solution for these patients. The surface char-
acter of SSEA-4 may be conducive to the efficient acquisition of ductal cells of
eccrine sweat glands and for clinical application in the future.
The skin serves as a physiological barrier that separates the
internal organs of the body from the external environment
and it performs a number of vital functions. Epidermal stem
cells play a key role in maintaining epidermis homeostasis by
providing a pool of new cells to replace those lost during skin
turnover.1 Moreover, the critical functions of the skin are also
fulfilled by accessory appendages in mammals, such as hair
follicles, nails, and sebaceous and sweat glands. These complex
structures consist of cells of both ectodermal and mesodermal
origin and to date multiple populations of stem cells that sup-
port the cyclic changes of the appendages during homeostasis
have been distinguished among them. Additionally, it has
been shown that these cells may participate in wound healing
in the case of injury.2 The population of nestin-positive stem
cells detected in human hair follicles, sebaceous and sweat
glands is one of the fields of interest of regenerative medi-
cine.3,4 However, detailed analysis has revealed that these cells
are localized exclusively in the connective-tissue sheaths of
human appendages.5 As cells of intramesenchymal skin com-
partments, they mainly enhance wound healing by releasing
bioactive molecules. Thus, they promote vascularization and
dermal regeneration rather than acting through direct differen-
tiation into epidermal cells in vivo.6–8 The epithelial cells of
hair follicles or sweat glands, on the other hand, not only
regenerate and repair appendages but may also migrate to the
interfollicular epidermis and support re-epithelialization dur-
ing wound healing.2,9,10
The treatment of deep and extensive burns often involves
the application of autologous epidermal cells expanded
in vitro.11 Although this approach ensures the restoration of the
epidermis, the sweat glands and other appendages do not
regenerate, which affects the quality of life of burn
patients.12,13 Thus, the search for cells with a higher potential
for differentiation, such as pluripotent stem cells, is justified.
Additionally, it would also be desirable to develop a relatively
simple method to isolate such cells for autologous cell-based
regenerative medical strategies.
The globoseries glycosphingolipid stage-specific embryonic
antigen-4 (SSEA-4) is a cell surface marker widely used to
define human pluripotent stem cells. SSEA-4 and SSEA-3 are
highly expressed in human embryonic stem cells or embry-
onal carcinoma cells and are downregulated upon differentia-
tion.14–17 However, the functions of SSEA-4 and its role as a
pluripotent marker remain controversial.18–21 Recently, SSEA-4
has also been described at the surface of cells residing in vari-
ous adult tissues, including cardiomyocyte progenitors or pan-
creatic ductal progenitor cells.22,23
In agreement with the latter, in this study we discovered
that ductal cells of human eccrine sweat glands also express
SSEA-4 on their surface. SSEA-4 was detected in all cells of
both layers at the full length of the duct, but not in the secre-
tory portion of sweat glands. Thus, the present article is, to
the best of our knowledge, the first description of SSEA-4 as a
novel marker exclusively present at the ductal but not secre-
tory cells of eccrine sweat glands.
Materials and methods
Human tissue
Skin biopsies were obtained from healthy patients of both
sexes undergoing plastic surgery. The informed consent and
prior approval of the local ethics committee were obtained
according to Polish law (No. KBET/72/B/2008). In order to
carry out flow cytometry analysis we used 28 biopsies
obtained from the following body sites: the abdomen, breast,
ears, eyelids, foreskin and labia minora. The age range of the
included patients was 11–61 years with a median age of 32
years. For immunohistochemical analysis we used 10 biopsies
obtained from the abdomen, breast, eyelids, foreskin and
palm. The age range of the included patients was 10–41 years
with a median age of 39 years.
Flow cytometry analysis
Human epidermal cells were isolated from skin biopsies.
Briefly, the skin sample was rinsed in phosphate-buffered sal-
ine (PBS) supplemented with penicillin (5000 U mL1) and
streptomycin (5 mg mL1) (both from Sigma-Aldrich, St
Louis, MO, U.S.A) and the subcutaneous tissue was removed.
The skin biopsy was cut into small pieces and digested in dis-
pase II (12 U mL1, Gibco, Grand Island, NY, U.S.A) over-
night at 4 °C. The following day the epidermis was detached
from the dermis and treated with 005% trypsin with 2 mmol
L1 ethylenediaminetetraacetic acid (Sigma-Aldrich) to isolate
the epidermal cells. The freshly isolated cells were filtered
with a 70-lm strainer, fixed with 37% paraformaldehyde for
20 min at room temperature and then washed with Perm/
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Wash Buffer (BD Biosciences, Franklin Lakes, NJ, U.S.A.). The
cells were labelled with the following monoclonal antibodies:
anti-CD45 Pacific Blue (Beckman Coulter, Brea, CA, U.S.A.),
anti-Lineage-FITC (CD2, CD3, CD14, CD16, CD19, CD24,
CD56, CD66b, CD235a, all from BD Biosciences) and
anti-SSEA-4-PE (BioLegend, San Diego, CA, U.S.A.) in concen-
trations suggested by the manufacturers for 30 min at room
temperature. Dead cells were excluded with 7-amino-actino-
mycin-D (BD Biosciences).
For transcription factors analysis, cells were analysed with
the BD Human Pluripotent Stem Cell Transcription Factor
Analysis Kit (BD Biosciences) according to the manufacturer’s
protocol. The kit contains the following mouse monoclonal
antibodies: Nanog-PE, Oct3/4-PerCP-Cy55 and Sox2-Alexa
Fluor 647. Additionally, anti-SSEA-4-AlexaFluor 488 mono-
clonal antibody (eBioscience, San Diego, CA, U.S.A) was
added. Appropriate isotype controls were included and gates
were set according to isotype-matched controls. Dead cells
were excluded with Hoechst 33258 (Sigma-Aldrich).
The cytometric analysis of the cells was performed on a
LSR-II Flow Cytometer (BD Biosciences) and data were evalu-
ated using the FACSDiva v.6 software (BD Biosciences).
Immunohistochemistry of human skin sections
Skin tissue specimens were fixed in 37% formaldehyde for 5
days and embedded in Tissue-Tek O.C.T (Fisher Scientific,
Pittsburgh, PA, U.S.A.) and then 6–8-lm cryosections were
cut for staining. Antigen retrieval was performed in 10 mmol
L1 citrate buffer pH 60 for 30 min at 95 °C.
For light microscopy, cryosections were stained using EnVi-
sion G|2 System/AP, Rabbit/Mouse (Permanent Red) Kit (Dako,
Glostrup, Denmark) according to the manufacturer’s protocol.
The following dilutions of primary antibodies were used:
mouse monoclonal anti-SSEA-4 (1 : 800, Merck Millipore, Bil-
lerica, MA, U.S.A), rabbit monoclonal anti-carcinoembryonic
antigen (CEA, 1 : 1000, Abcam, Cambridge, U.K.), rabbit
monoclonal anti-keratin 7 (K7, 1 : 400, Abcam), mouse mono-
clonal anti-a smooth muscle actin (aSMA, 1 : 3000, BD Bio-
sciences) and mouse monoclonal anti-keratin 10 (K10,
1 : 2000, Abcam). After having been stained, the cryosections
were counterstained with Mayer’s haematoxylin solution,
mounted with Glycerol Mounting Medium (Dako) and then
examined with an Olympus BX51 microscope with a VC50
camera (Olympus Co., Tokyo, Japan).
For immunofluorescence, cryosections were preincubated
with 5% normal goat serum (Sigma-Aldrich) in PBS for 1 h.
Next, mouse monoclonal anti-SSEA-4 (1 : 100, Merck Milli-
pore) with rabbit monoclonal anti-CEA (1 : 200, Abcam) or
rabbit monoclonal anti-K7 (1 : 200, Abcam) was added for 2
h and then visualized with goat antimouse-AlexaFluor 488
(1 : 300) and goat anti-rabbit-AlexaFluor 546 (1 : 600, both
from Invitrogen, Carlsbad, CA, U.S.A.) secondary antibodies.
All dilutions of antibodies were prepared in 3% bovine serum
albumin with 005% Tween-20 in PBS. Nuclei were stained
with Hoechst 33258 (Sigma-Aldrich). Cryosections were
mounted with Fluorescent Mounting Medium (Dako) and
then examined with a Leica TCS SP5 confocal microscope
equipped with Leica Las AF software (Leica Microsystems,
Wetzlar, Germany).
Statistical analysis
Statistical analyses were carried out from at least three inde-
pendent samples using the Kruskal–Wallis test in Statistica 10
software (StatSoft, Tulsa, OK, U.S.A.); P < 005 was consid-
ered statistically significant, n refers to the number of the anal-
ysed samples from different patients.
Results
Nonpluripotent stage-specific embryonic antigen-4-
positive cells are present in human epidermis
Firstly, we investigated whether cells positive for embryonic
stem cell marker SSEA-4 are present in adult human epidermis.
A multicolour flow cytometry analysis of freshly isolated epi-
dermal cells was performed and cells of haematopoietic origin
(Lin+/CD45+) were excluded (Fig. 1a). Interestingly, we
identified a distinct population of cells expressing SSEA-4 at
their surface. Given that SSEA-4 is a marker characteristic of
embryonic stem cells, we reasoned that SSEA-4+ cells present
in the epidermis might be pluripotent. Oct-4, Nanog and Sox-
2 are three pluripotent transcription factors that are well
known as master regulators of stem cell pluripotency.24 How-
ever, the results obtained from the flow cytometry analysis
showed that SSEA-4+ cells did not express any of these tran-
scription factors, so they did not correspond to the population
of primitive stem cells in adult human epidermis (Fig. 1b).
We estimated that the average number of epidermal
SSEA-4+ cells was 264  115 per 100 000 analysed events
(n = 10). We observed significant differences in the number
of SSEA-4+ cells between the analysed samples; however, we
did not find any association between the number of these cells
and the patients’ age or sex. Surprisingly, the data obtained
revealed an unambiguous correlation between the number of
SSEA-4+ cells and the anatomical site of the body, indicating
that these cells are most abundant in the abdomen and breast
epidermis [2217  539 and 510  72 (n = 5) per 100 000
analysed events, respectively]. We found that the number of
SSEA-4+ cells was lower and amounted to 346  77 (n = 5)
and 327  32 (n = 3) in the case of epidermis isolated from
the ears or eyelids, respectively. The smallest SSEA-4+ cell
population was observed in epidermis from the genitals, in
which we detected 157  20 (n = 5) cells in the foreskin and
only 8  1 (n = 5) cells in the labia minora (Fig. 1c).
Epidermal stage-specific embryonic antigen-4-positive
cells are localized in orifices of sweat gland ducts
Next, we used immunohistochemical staining of skin tissue
cryosections to identify the precise localization of SSEA-4+
© 2017 The Authors. British Journal of Dermatology
published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
British Journal of Dermatology (2017) 176, pp1541–1548
SSEA-4 as a novel marker of ductal cells of sweat glands, J. Borowczyk-Michalowska et al. 1543
cells in human epidermis. We did not find SSEA-4+ cells
within the rete ridges, a common niche of epidermal stem
and progenitor cells, or anywhere along the basal layer, or in
any other layer of differentiating cells (Fig. 2a). However, we
noticed cells expressing SSEA-4 within single elongated and
spiral structures. The observed structures traversed all layers of
epidermis and opened directly onto the skin surface (Fig. 2b).
Additionally, the skin samples analysed from different body
regions varied in the number of structures in agreement with
previously obtained results from flow cytometry (data not
shown).
Surprisingly, we identified the observed structures as
intraepidermal parts of eccrine sweat gland ducts, called the
acrosyringia. Thus, we conclude that SSEA-4 is not present on
the surface of cells residing in the interfollicular epidermis
itself, but is present in its appendages (i.e. sweat glands). The
acrosyringium spirals through the surface epidermis in a cork-
screw pattern that is preserved even in cornified layer, such as
in the section from a palm (Fig. 2b).
Stage-specific embryonic antigen-4 is expressed in
ductal but not secretory cells of eccrine sweat glands
Then, we asked whether the SSEA-4 was present only in the
intraepidermal sweat duct unit or whether it was present in
the whole structure of the gland. With further immunohisto-
chemical analyses, we confirmed the presence of SSEA-4 in all
cells located along the full length of the sweat gland duct, that
is in the spiralled intraepidermal acrosyringium (Fig. 2b) and
all the way through the dermis (Fig. 2c) to the coiled section
leading to the secretory portion (Fig. 2d, e). It seemed that
SSEA-4 was present at the surface of both basal and suprabasal
layers of cuboidal epithelial cells of ducts. A similar staining
pattern was observed in all examined eccrine sweat glands both
in samples of glabrous and nonglabrous skin (Fig. 2b–e).
Intriguingly, we did not observe SSEA-4 expression in the lumi-
nal or myoepithelial cells of the secretory portion (Fig. 2d, e).
To confirm the localization of the glycosphingolipid anti-
gen, we conducted double immunofluorescent staining of the
cryosections. CEA is generally considered as a cell surface mar-
ker of human sweat glands.25 CEA is present at the luminal
surface of the secretory and ductal cells in eccrine sweat
glands, with the latter showing stronger labelling.26 K7, on
the other hand, is expressed solely in the luminal cells of the
secretory coil.25 Our results clearly showed the coexpression
of SSEA-4 and CEA in the luminal membranes of the supraba-
sal cells of sweat ducts, whereas, as expected, the basal cells
were labelled only with SSEA-4 (Fig. 3a). For the secretory
portion, only CEA was detected in the luminal membranes of
the secretory cells (Fig. 3a). In addition, the absence of SSEA-
(a)
(b) (c)
Fig. 1. Non-pluripotent stage-specific embryonic antigen-4 (SSEA-4)+ cells are present in adult human epidermis. (a) Flow cytometric analysis
showing the gating strategy of enzymatically isolated cells from human epidermis. The cells were analysed for SSEA-4 antigen expression after
excluding cells of haematopoietic origin (Lineage+, CD45+). (b) Flow cytometric analysis of expression of pluripotency transcription factors; that
is Oct-4, Nanog and Sox-2, in SSEA-4+ cells. (c) Quantification of SSEA-4+ in skin samples collected from specific body sites. Results are
normalised per 100 000 analysed events and presented as means  SEM (n = 5, except for eyelids with n = 3). Significance: P < 005 tested by a
Kruskal–Wallis test. FSC, forward scatter; SSC, side scatter; L. minora, labia minora.
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4 coexpression with K7 confirmed that the presence of the
glycosphingolipid antigen is restricted to the ductal cells and
is not found in the secretory coil (Fig. 3b).
Discussion
Standard treatment of deep and extensive burns with in vitro
cultured cells mainly focuses on restoring the epidermis as a
barrier to prevent loss of body fluids and to protect against
the invasion of pathogens. However, this approach does not
ensure the regeneration of accessory appendages, leading to
the disturbance of some pivotal functions of the skin, that is
ultraviolet protection, thermoregulation or sebum produc-
tion.1 There are high hopes over modifications of cell therapy
that would promote both epidermis and appendage regenera-
tion and thus be a solution for burns patients.
In light of hopes for the clinical application of epidermal
cells in treating skin lesions, we strove to find a cell popula-
tion in human epidermis that would meet these expectations.




Fig. 2. The expression pattern of stage-specific embryonic antigen-4 (SSEA-4) and sweat gland markers in human skin. Analysis of SSEA-4 antigen
expression: (a) the interfollicular epidermis, breast; (b) the acrosyringium, palm; (c) the intradermal straight duct, breast; (d, e), proximal
reabsorption and secretory portion of the eccrine sweat glands, breast and abdomen. Staining of sweat gland markers: (f) carcinoembryonic antigen
(CEA) present in luminal membranes of both secretory and ductal cells, breast; (g) a smooth muscle actin (aSMA) expressed in myoepithelial cells,
abdomen; (h) keratin 7 (K7) localized only in luminal cells in the secretory coil of sweat glands, palm; (i) keratin 10 (K10) absent from sweat glands,
breast. Ducts indicated by arrowheads; secretory portion indicated by arrows; (a–c) 9 200, (d–i) 9 400. Scale bars 50 lm.
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population expressing SSEA-4 at the surface after standard
enzymatic digestion of epidermis with trypsin. Contrary to
our assumption, we found that these cells were not localized
in the interfollicular epidermis but in its appendages; namely,
in the sweat glands. Although in humans eccrine sweat glands
are distributed widely on the body surface, there are clear
regional differences in their density.27 Our study revealed that
SSEA-4 is generally expressed in the ductal cells and thus, the
observed differences in SSEA-4+ cell number in analysed epi-
dermis samples most likely resulted from the variance in sweat
gland density in particular regions of the human body.28 The
extremely low number of SSEA-4+ cells detected in labia min-
ora epidermis compared with other samples is justified, as the
presence of eccrine sweat glands in this area is still controver-
sial.29,30 Although the functions of sweat glands have been
known since the early 1950s, there is still little information
on their regenerative potential.31,32
Several reports have documented the proliferation of disso-
ciated sweat gland cells in culture and have shown the contri-
bution of in vitro cultured sweat gland cells to epidermal repair
after skin grafting.33,34 Recently, Lu et al. reported their identi-
fication of three types of adult cell progenitors within the
sweat gland and its duct in mice.35 Although all progenitors
actively participated in gland regeneration, only basal progeni-
tors within sweat gland ducts were found to respond and pro-
liferate after epidermal injury. In addition, they regenerated
the sweat duct orifice and did not participate in the interfollic-
ular epidermis repair.35 In contrast, experiments conducted on
human skin revealed that eccrine sweat glands contribute sig-
nificantly to re-epithelialization after partial thickness wounds
and demonstrated the important role of ductal cells of human
eccrine sweat glands in epidermal repair.9,10 Thus, these find-
ings provide compelling evidence in support of the notion
that the cells located in sweat ducts may be the source of the
cells that regenerate not only ductal orifices but also the epi-
dermis after injury.
Generally, the sweat gland is a tiny coiled tubular struc-
ture that consists of a secretory unit producing sweat and a
duct carrying the sweat away. The reabsorptive duct of the
eccrine gland is a straight two-layered channel opening at
the surface of the epidermis.27 The cystic fibrosis transmem-
brane conductance regulator (CFTR) and a glycoprotein CEA
are extracellular markers known to be expressed in the ducts
of sweat glands; however, their presence is limited to the
luminal cell layer.26,36 Here we show that, in contrast to
these markers, SSEA-4 is also expressed in cells residing in
the basal layer. To date, a surface antigen specific for the
ductal cells of eccrine sweat glands has not been discovered.
In the light of these results and to our best knowledge,
SSEA-4 may be the first described marker for these cells. Our
article confirms that the expression of SSEA-4 is not
restricted to pluripotent human cells.18,21,37 Moreover, this is
the second demonstration that SSEA-4 is present in the ducts
of glandular structures, that is the pancreas and sweat
glands.23 The role played by glycosphingolipid SSEA-4 at the
surface of ductal cells, and whether it is associated with the
potential of these cells to proliferate and differentiate into
other cell lineages, remains unknown.
The question of whether SSEA-4 expression is unique for
eccrine sweat glands or whether it also occurs in apocrine or
(a)
(b)
Fig. 3. The expression of stage-specific embryonic antigen-4 (SSEA-4) antigen in human sweat glands. (a) Confocal microscopy analysis of tissue
cryosections stained with antibodies against SSEA-4 (green) and carcinoembryonic antigen (CEA) (red) or (b) SSEA-4 (green) and keratin 7 (K7)
(red). Nuclei (blue) were counterstained with Hoechst 33258. Scale bars 10 lm.
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mammary glands remains open. Further research is urgently
needed to settle this question because the results would be of
particular interest for the development of tumour diagnostic
markers. Among other considerations, it is still difficult to dis-
tinguish primary sweat gland carcinomas from cutaneous
metastases of breast carcinomas or apocrine and eccrine meta-
static sweat gland carcinomas because of their similar mor-
phology and their origin as epidermal appendages.38–40 As the
treatment for these carcinomas differs it is of clinical impor-
tance to identify more reliable markers to distinguish between
them: SSEA-4 may be useful in this respect.
To summarize, we have identified a population of cells
within the adult human epidermis that expresses embryonic
antigen SSEA-4 on its surface. The data obtained enabled us to
point to SSEA-4 as a newly discovered marker of the ductal
cells of eccrine sweat glands. Currently, intensive research has
been directed at finding effective treatment methods for
patients with an irreversible loss of functional eccrine sweat
glands. Because the evaporation of sweat is the body’s primary
mechanism for heat loss, hyperthermia is generally thought to
be a problem for most burns patients, affecting the quality of
their lives.25,26,41 The surface character of SSEA-4 may be con-
ducive to the efficient acquisition of ductal cells of sweat
glands and may become a useful marker in tumour diagnosis
and thus find clinical application in the future.
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